COVID Vaccine Postmarket Monitoring Will Depend On Which Adverse Events US FDA Wants To Watch

 
• By Derrick Gingery
  
Data monitoring (Titima Ongkantong/Shutterstock.com)
Those who receive a vaccine after approval will be alerted electronically to get their second dose, as well as report adverse events. • Source: Shutterstock

More from Vaccines

More from Pink Sheet